Gabriel Jones, the co-founder and CEO of Proprio, shares insights on the surgical robotics company’s technology and plans.
NVIDIA heralds ‘physical AI’ era with Cosmos platform launch
With Cosmos, NVIDIA aims to bring AI from our screens to the real world, where it can can perceive, understand, and interact with the world.
As PillBot clinical trials continue, Endiatx CEO plots next moves
As 2024 draws to a close, Endiatx has ongoing clinical trials for PillBot 1.0 in New Zealand, and is currently developing PillBot 2.0.
Rani prices $73M IPO for robotic drug-delivery pill
Rani developed a proprietary platform, RaniPill, designed to provide a pill-based alternative to intravenous or subcutaneous administration of biologics.